Recent Headlines
Europital Will Provide a Key Presentation at the CTIP Congress in Hamburg, Germany
Europital will be present at the Clinical Trials Innovation Programme on the 27th and 28th of June at the Radisson Blu Hotel Hamburg Airport, in Hamburg, Germany. - June 10, 2016 - Europital BVBA
Autoinjectors Market to Grow at 8% Annually, Predicts Roots Analysis
The "Global Autoinjectors Market, 2016-2026" report elaborates on self-administration devices, the origin/history of autoinjectors, their components and advantages offered by different categories of autoinjectors. - June 08, 2016 - Roots Analysis
Seven Presentations on electroCore’s Treatment for Cluster Headache and Migraine Will Feature at American Headache Society Science Meeting
Recent clinical and preclinical results using electroCore’s non-invasive vagus nerve stimulation (nVNS, gammaCore®) therapy in the treatment and prevention of primary headache are the subject of seven presentations at the American Headache Society (AHS) Science Meeting being held at San... - June 08, 2016 - electroCore
ALPCO Releases New Broad Range Periostin ELISA
ALPCO now has a new broad range Periostin ELISA capable of measuring elevated levels of periostin consistent with current research. - June 07, 2016 - ALPCO
Agati Systems Announces New Website Launch
Agati Systems, a Healthcare and Global Life Sciences company, have come out with an upgraded website with updated and trending features. The user-friendly content and interactive interface has started to increase user traffic to the site. - June 02, 2016 - Agati Systems
Korea and Thailand: The ASAlaser Strategy to Open New Markets
Whether it is MLS® Laser Therapy or Hilterapia® or Qs Magnetotherapy, the company from Vicenza promotes training as the essential factor to obtain tangible and functional results for the growth of the activities of those choosing its therapy solutions. - May 18, 2016 - ASA srl
electroCore's GammaCore is Both Effective and Cost Effective for the Treatment of Cluster Headache
A paper in the Journal of Headache and Pain reports that non-invasive stimulation of the vagus nerve (nVNS) is a cost effective therapy for cluster headache. These findings were based on reductions in medication use and improvements in quality of life. The publication also notes that further... - May 18, 2016 - electroCore
TriFoil Installs Russia’s First 3D Optical Imager in Novosibirsk
In February 2016, TriFoil Imaging in collaboration with GenMedica Baltic Ltd and assistance of BioVitrum Ltd installed Russia’s first 3D Optical imaging system, the InSyTe FLECT/CT. The system was installed under the operation of Prof. Evgeny Zavyalov, head of SPF Vivarium Department of... - May 17, 2016 - TriFoil Imaging
Affinity Biologicals, a Manufacturer of Thrombosis and Hemostasis Research Products, Announces Involvement in the ISTH SSC 2016 Meeting
The 62nd Annual Meeting of the Scientific and Standardization Committee (SSC) of the International Society of Thrombosis and Hemostasis (ISTH) begins on May 25th in Montpelier, France, and will continue through to the 28th. Affinity Biologicals will participate in the event through a discussion of products with clients and networking with other researchers in the field. - May 14, 2016 - Affinity Biologicals
New Rule Helps Public Health Agencies Track and Prevent Workplace Injury and Illness
Nearly 5,000 workers die each year and millions are injured on the job in the U.S., costing roughly $250 billion per year. This amount is more than the cost of many other common diseases. The federal Occupational Safety and Health Administration (OSHA) yesterday released a new rule requiring employers to electronically report to OSHA all work-related injuries and illnesses. This new rule will significantly improve the capacity for states to track and prevent work-related injuries and illnesses. - May 12, 2016 - Council of State and Territorial Epidemiologists
South Korean Ambassador Tours Start-Up Businesses at HCDC with Congressman Steve Chabot
The purpose of the visit was to present the Ambassador examples of American business, from start-up size such as those he visited at HCDC like GeckoTek, Resolution Air, General Nano, and Sense Diagnostics, to multi-national corporations like Kroger, Fifth Third Bank and Procter & Gamble. - May 12, 2016 - HCDC, Inc.
National Brain Tumor Society Statement on Revised World Health Organization Classification of Tumors of the Central Nervous System
National Brain Tumor Society (NBTS), the largest nonprofit organization in the U.S. dedicated to the brain tumor community, today released the following statement from David F. Arons, Chief Executive Officer, on the publishing of the 2016 updated World Health Organization (WHO) Classification of... - May 12, 2016 - National Brain Tumor Society
Europital Will be Present at Knowledge for Growth 2016
Europital will participate for second consecutive time in the “Knowledge for Growth” event that takes place every year at the ICC Building in Ghent, Belgium. - May 08, 2016 - Europital BVBA
MR Solutions to Display Cryogen-Free MRI Imaging Systems at ISMRM in Singapore
MR Solutions will be displaying its latest ground-breaking preclinical cryogen-free MRI imaging systems at ISMRM in Singapore from May 7 to 13. This includes details of a new 9.4T cryogen-free scanner and a compact 3T system with a 12cm bore which are coming soon. All of MR Solutions’... - May 08, 2016 - MR Solutions
Zifo Technologies Rebrands as Zifo RnD Solutions Globally
Zifo Technologies has announced that it has adopted a new brand name of “Zifo RnD Solutions” from May 1, 2016 for its offerings in the R&D space. Zifo RnD Solutions offerings will span across Discovery Informatics, Lab Automation, Clinical Services, Translational Research and the Genomics Space. - May 07, 2016 - Zifo
The Morgan Leary Vaughan Fund Honors Dr. Edmund F. La Gamma
The Morgan Leary Vaughan Fund honored Edmund F. La Gamma, MD, Chief, Newborn Medicine at Maria Fareri Children's Hospital, a Member of the Westchester Medical Center Health Network, with the inaugural Lily Pedro Award for Excellence. The event, The 1st Annual Morgan's FunDay, was held at the... - May 05, 2016 - The Morgan Leary Vaughan Fund, Inc.
Pediatric Brain Tumor Foundation's New Campaign Aims to Raise Awareness in May and Every Day
The Pediatric Brain Tumor Foundation believes the conversation about brain tumors is bigger than just one month. That’s why the world's largest nonprofit funder of childhood brain tumor research is kicking off Brain Tumor Awareness Month with the “May and Every Day” campaign. - May 02, 2016 - Pediatric Brain Tumor Foundation
Europital Launches Its New Website
Europital has officially launched its new website, a new and completely renovated concept to improve users experience, simplify navigation and facilitate visitors’ ability to access company’s relevant information. - May 01, 2016 - Europital BVBA
Pediatric Brain Tumor Foundation Introduces Free Toolkit for Newly Diagnosed Families
The Pediatric Brain Tumor Foundation is pleased to announce the publication of the Star Portfolio, a new resource for families of children recently diagnosed with a brain tumor. “Our new Star Portfolio is a toolkit designed to help families of newly diagnosed brain tumor patients partner... - April 28, 2016 - Pediatric Brain Tumor Foundation
Compounding Pharmacy Supplies Medication for Study Using Edetate Disodium Therapy
Following the generally positive outcome of the National Institutes of Health-funded Trial to Assess Chelation Therapy (TACT)[1] study completed in 2012, it was decided that further research was warranted to test the safety and effectiveness of Chelation therapy as a treatment option for... - April 27, 2016 - Universal Arts Compounding Pharmacy
ALPCO’s Bioactive Leptin ELISA Allows Researchers to Differentiate Between Leptin Resistance and Non-functional Leptin
ALPCO recently announced the release of its Bioactive Leptin ELISA, offering diabetes and obesity researchers a new tool to differentiate between leptin resistance and non-functional leptin. The assay allows for the measurement of leptin in human serum through the process of binding leptin to... - April 26, 2016 - ALPCO
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study
Bioquark Inc. and Revita Life Sciences Receive IRB Approval for First-In-Human Brain Death Study - The Reanima Project - Is Death Reversible? - April 25, 2016 - Bioquark Inc.
MR Solutions Wins Queen’s Award for Enterprise
MR Solutions, of Guildford has won the prestigious Queen’s Award for Enterprise in the innovation category. This award is announced on the Queen’s birthday, 21 April and is one of the UK’s highest accolades recognising business achievement. This has been achieved in recognition... - April 23, 2016 - MR Solutions
Fahad Al Tamimi to Host a Special Dinner in Support of Research Into Radiation Therapy
Fahad Al Tamimi will welcome high profile guests in London next week to support further research into the area of radiation therapy. - April 22, 2016 - Fahad Al Tamimi Philanthropy
Morgan's Fund Issues Statement on Selection for NORD's Natural History Studies Project
A statement was issued today by Stephanie M. Vaughan, Co-founder and President of The Morgan Leary Vaughan Fund (Morgan’s Fund), regarding the announcement of the National Organization for Rare Disorders’ (NORD) selection of Natural History Studies Project participants. - April 22, 2016 - The Morgan Leary Vaughan Fund, Inc.
Nanohybrids Expands Nanoparticle Product Line with Launch of 30 nm Gold Nanospheres
NanoHybrids releases 30 nm spherical gold nanoparticles. With this product launch NanoHybrids now offers a full complement of NanoSphere products ranging in diameter from 5 nm to 60 nm. Various surface coatings are also available to suit a wide range of application needs. - April 20, 2016 - NanoHybrids
BreviTest Awarded Grant from National Institute on Drug Abuse to Optimize Device for Rapid Cannabis Testing
BreviTest Technologies has been awarded a $234,412 grant from the National Institute on Drug Abuse of the National Institutes of Health (NIH) to explore rapid testing for THC, the main active ingredient in cannabis. The federal funds, awarded under the NIH’s Small Business Innovation Research... - April 14, 2016 - Cayman Chemical Company
Cesar Chavez Lifetime Achievement Award Given to North County Health Services’ CEO
The network of 11 clinics has become a medical home for over 62,000 patients and clients for nearly two decades. - April 13, 2016 - NCHS
NICE Provides Positive Guidance on electroCore’s gammaCore Treatment for the Prevention and Acute Treatment of Migraine and Cluster Headache
The UK’s National Institute of Health and Care Excellence (NICE) has published guidance that electroCore’s non-invasive vagus nerve stimulation treatment (gammaCore) for the prevention and acute treatment of migraine and cluster headache is safe and can now be used in the NHS. The... - April 09, 2016 - electroCore
ALPCO's New Chemiluminescent IL-6 ELISA Delivers Flexibility and Cost Savings
ALPCO announced the launch of its new STELLUX® Chemi Human IL-6 ELISA - the first cytokine assay in the STELLUX® Chemiluminescence product line. - April 06, 2016 - ALPCO
African Biosciences Inc. Launches First Ever E-Commerce Platform for Bioscience Reagents and Supplies in Nigeria
African Biosciences Ltd., a subsidiary of US-based African Biosciences Inc. today announced the launching of the first ever e-commerce platform in Nigeria to provide reagents and supplies to the bioscience and clinical research community. African Biosciences Ltd. is the first company to use an e-commerce driven model to deliver reagents and supplies to meet the needs of researchers into the biology of animals, humans, microbes and plants and medical testing laboratories in Nigeria. - April 04, 2016 - African Biosciences Inc.
Video Series Educates Families on Brain Tumors
In the Pediatric Brain Tumor Foundation’s new Family Support Learning Series videos, leading brain tumor experts discuss topics such as clinical trials, genetic susceptibility and molecular testing. - March 31, 2016 - Pediatric Brain Tumor Foundation
Hematogenix Laboratory Services, LLC Announces the Availability of FDA Approved PD-L1 Companion Diagnostic Tests
Hematogenix Laboratory Services Announces the Availability of PD-L1 Companion Diagnostic Tests for KEYTRUDA®, Merck's Anti-PD-1 Therapy for Metastatic Non-Small Cell Lung Cancer Whose Tumors Express PD-L1 with Disease Progression on or after Platinum-Containing Chemotherapy as well as a PD-L1 Complementary Diagnostic Test to Support Bristol-Myers Squibb's OPDIVO® Anti-PD-1 Therapy for Non-Squamous Non-Small Cell Lung Cancer. - March 24, 2016 - Hematogenix
MiTeGen Announces Their In Situ-1 Crystallization Plates Have Been Selected for Use in Microgravity Crystallization Experiments Aboard the International Space Station
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced that a line of their products, the In Situ-1™ crystallization plates, will be used for research conducted on the International Space Station (ISS). - March 24, 2016 - MiTeGen, LLC
TrialX Launches America Walks, the First Mobile-Based Walking Study on iOS and Android Using Apple’s ResearchKit Technology
TrialX announced the launch of “America Walks,” a mobile based research study (http://trialx.com/americawalksstudy) to determine the walking behavior of Americans. The study is the first mobile app based study to be available on both iOS and Android devices. The America Walks App has been built using Apple’s ResearchKit Library and the team at TrialX has also ported the same for Android devices so that the app is available to a much larger population base. - March 24, 2016 - Applied Informatics
MFB Fertility, LLC Develops Only In-Home Test to Detect Progesterone
Research has shown that couples get pregnant faster when they know when exactly when ovulation takes place. Fertility monitors and ovulation predictor kits allow couples to track estrogen and luteinizing hormone (LH) levels from home. However, until now, there were no tests available to track progesterone. - March 23, 2016 - MFB Fertility, LLC
North County Health Services Opens New Location in Perris, California
North County Health Services (NCHS), a leading provider of health care, announces the opening of their newest health care facility. Families and individuals that are looking for medical attention can stop by NCHS’ newest location at 1675 N Perris Blvd, Perris, CA 92571 for all of their medical needs. - March 22, 2016 - NCHS
HPAPIs and Cytotoxic Drugs: The Growing Opportunity for Contract Manufacturers
Roots Analysis has announced the addition of HPAPIs and Cytotoxic Drugs Manufacturing Market, 2016-2026 (2nd edition) report to its portfolio. The report provides an extensive study of the contract manufacturing opportunity in this rapidly expanding market. The focus of this report is primarily to... - March 21, 2016 - Roots Analysis
NSF Funds NanoHybrids’ Improved Chemotherapy Delivery Platform
NSF SBIR grant to be used to advance nanoparticle platform for safe, effective, and controlled cancer drug delivery. - March 16, 2016 - NanoHybrids
Specialty CROs: The Future of R&D Outsourcing
Roots Analysis has announced the addition of Specialty CROs Market, 2016-2025 report to their offering. The report delivers a comprehensive study on Contract Research Organizations (CROs) that offer specialized sets of research capabilities/services, focused on a particular stage of clinical... - March 07, 2016 - Roots Analysis
National Sales Manager Announced for Stat-Technologies
Stat-Technologies, the premier distributor of point of care testing products, announced today that they have promoted Angela Hansen to National Sales Manager. Angela has been with Stat since 2008 as a territory representative and marketing manager for Oxygen, the paperless data collection... - March 05, 2016 - Stat-Technologies
Speaking of NEC Podcast Retrospective Launches February 28
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant NEC experts - neonatologists, clinicians and researchers - that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - February 27, 2016 - The Morgan Leary Vaughan Fund, Inc.
Clinical Research Forum Congratulates Co-Founder on U.S. Food and Drug Administration Appointment
Formed in 1996, the Clinical Research Forum convenes annually to allow industry leaders to discuss issues facing the field, best practices, and promote understanding and support for clinical research and its impact on health and healthcare. Through its activities, the Forum has increasingly played a national advocacy role in supporting broader interests and needs of clinical research. For more information, visit www.clinicalresearchforum.org. - February 26, 2016 - Clinical Research Forum
MR Solutions Brings New 3D, 1000X Magnification Imaging Modality to Preclinical Research
MR Solutions’ new 3D in vivo confocal microscope for use in preclinical research provides a magnification range of up to 1000 times, allowing researchers to examine cellular details within a live small animal eliminating the need for a surgical biopsy - saving time and substantially reducing costs. - February 24, 2016 - MR Solutions
ALPCO's New NT-proBNP ELISA Offers Cost Savings and Flexibility
ALPCO recently announced the release of its new NT-proBNP (1-76) ELISA, offering researchers investigating cardiovascular disease, kidney disease, and diabetes with a flexible, user friendly and cost effective tool. The assay is highly characterized to measure changes in levels of NT-proBNP, and... - February 23, 2016 - ALPCO
ALPCO Releases New Basophil Activation Test Validated for the Evaluation of Kinase Inhibitors in Early Drug Development
ALPCO has released its new InhibiScreen Basophil Activation Test (BAT) which was developed and validated specifically for the evaluation of kinase inhibitors during early drug development. - February 16, 2016 - ALPCO
Peptide Therapeutics: The Growing Hope for Metabolic Disorders
Roots Analysis has announced the addition of “Peptide Therapeutics in Metabolic Disorders, 2016-2025” report to its portfolio. The report provides a comprehensive study on the current market landscape and the future outlook of the evolving pipeline of peptide therapeutics that are being... - February 16, 2016 - Roots Analysis
Don Barbo Returns to VMG Health’s Business Valuation Practice
VMG Health welcomes back Don Barbo as a managing director in healthcare business valuation services. - February 13, 2016 - VMG Health
Fertility Preservation Network Welcomes Albuquerque, New Mexico Facility
Program greatly extends access to fertility preservation services - February 12, 2016 - ReproTech, LLC
Studies Use Epitope Diagnostics’ ELISA Kit to Establish Chromogranin A as a Potential Prognostic Marker in Prostate Cancer Patients Treated with Antiandrogens
Italian research group uses Epitope Diagnostics' Chromogranin A ELISA kit in study to determine CgA as a potential prognostic marker in castration-resistant prostate cancer patients treated in abiraterone or enzalutamide. - February 11, 2016 - Epitope Diagnostics, Inc.